IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Carbogen Amcis Partners with ADC Biotechnology

8:07 AM MDT | September 25, 2012 | Deepti Ramesh

Carbogen Amcis (Bubendorf, Switzerland), a pharma process-development and active pharmaceutical ingredient (API) manufacturing subsidiary of Dishman Pharmaceuticals and Chemicals (Ahmedabad, India) says it has entered into a collaboration with ADC Biotechnology (ADC Bio; Denbighshire, U.K.) to provide customers with seamless development and manufacturing services for antibody-drug conjugates (ADCs)—a key anticancer treatment platform. The alliance will offer a range of services to customers for the development, scale-up, manufacturing, and formulation...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa